J&J sues Amgen over cancer drug sales tactics

10/14/2005 | NYTimes.com

Johnson & Johnson filed an antitrust suit alleging Amgen used sales tactics to force cancer clinics to buy its Aranesp rather than J&J's Procrit, drugs used to treat chemotherapy-related anemia. The suit notes U.S. sales of the two drugs are expected to reach $2.8 billion this year. An Amgen spokeswoman said, "We believe the allegations are not legitimate and we intend to fight this."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA